TrialThe New England journal of medicine2012
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Keith T Flaherty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,332 papers cite itlatest 60 shown
this paperpooled ittrialcites it